Package 0069-0106-01

Brand: elelyso

Generic: taliglucerase alfa
NDC Package

Package Facts

Identity

Package NDC 0069-0106-01
Digits Only 0069010601
Product NDC 0069-0106
Product ID 0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821
Description

1 VIAL, GLASS in 1 CARTON (0069-0106-01) / 5 mL in 1 VIAL, GLASS

Marketing

Marketing Status
Marketed Since 2012-05-01
Brand elelyso
Generic taliglucerase alfa
Sample Package No

Linked Drug Pages (1)

ELELYSO ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "d7eb51c8-fe18-46f2-8d97-eaa343ec8821", "openfda": {"nui": ["N0000175820", "M0009360"], "unii": ["0R4NLX88O4"], "rxcui": ["1292879", "1292881"], "spl_set_id": ["fa3cbd5d-677c-4b19-9032-d9182cb69a83"], "pharm_class_cs": ["Glucosylceramidase [CS]"], "pharm_class_epc": ["Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, GLASS in 1 CARTON (0069-0106-01)  / 5 mL in 1 VIAL, GLASS", "package_ndc": "0069-0106-01", "marketing_start_date": "20120501"}], "brand_name": "ELELYSO", "product_id": "0069-0106_d7eb51c8-fe18-46f2-8d97-eaa343ec8821", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Glucosylceramidase [CS]", "Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"], "product_ndc": "0069-0106", "generic_name": "Taliglucerase alfa", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ELELYSO", "active_ingredients": [{"name": "TALIGLUCERASE ALFA", "strength": "200 U/5mL"}], "application_number": "BLA022458", "marketing_category": "BLA", "marketing_start_date": "20120501", "listing_expiration_date": "20261231"}